Clinical trials
Phase 2/3 Myositis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
9 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Abcuro, Inc. | 1 |
| Ashibio Inc | 1 |
| Cabaletta Bio | 1 |
| National Institute of Environmental Health Sciences (NIEHS) | 1 |
| Northwell Health | 1 |
| Novartis Pharmaceuticals | 1 |
| Restem, LLC. | 1 |
| Richard Barohn, MD | 1 |
| argenx | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Myositis | 9 |
| Dermatomyositis | 5 |
| Myositis, Inclusion Body | 3 |
| Muscular Diseases | 2 |
| Polymyositis | 2 |
| Autoimmune Diseases | 1 |
| Calcinosis | 1 |
| Hallux Valgus | 1 |
| Inflammation | 1 |
| Muscular Atrophy | 1 |
Trials
Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.